Limiting AAA With Metformin (LIMIT) Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Abdominal Aortic Aneurysm
Interventions
DRUG

Metformin

Smaller studies have suggested that metformin may reduce the rate at which aortic aneurysms enlarge. This study will test this question: does metformin prevent AAAs from growing larger?

OTHER

Placebo

One group will be randomized to receive the study drug Metformin and the other group will receive a placebo

Trial Locations (1)

94305

RECRUITING

Stanford Hospital and Clinics, Stanford

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

VA Palo Alto Health Care System

FED

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Stanford University

OTHER